A new type of cell-based immunotherapy shows promise for B-cell lymphomas, and due to innovations in manufacturing, could ...

A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 ...

A phase 1 clinical trial co-led by researchers at Washington University School of Medicine in St. Louis found that a new type ...

Lithium-ion batteries manufacturer the International Battery Company (IBC) is set to commence production at its 'Giga Factory ...

Fighting off infections when one has a chronic disease is a common problem, and during the COVID-19 pandemic that scenario ...

In an intriguing revelation from recent research, mitochondria have been shown not only to power the cell but also to ...

An individual B cell will produce only a single species of antibody fitting a mere one or very few antigenic shapes. That B cell is just as picky about what antigen it will pay attention to ...

Devimistat is under clinical development by Cornerstone Pharmaceuticals and currently in Phase II for Unspecified B-Cell Lymphomas.

Amid increasing demand for power generation, British Columbia's energy minister says the province remains committed to ...

Sana Biotechnology, Inc. shares surge as a breakthrough in diabetes therapy sparks investor interest. Click for my updated ...